Related references
Note: Only part of the references are listed.Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
Teemu J. Murtola et al.
BRITISH JOURNAL OF CANCER (2018)
The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer
Eric A. Miller et al.
CANCER CAUSES & CONTROL (2018)
Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer
Tuomas P. Kilpelainen et al.
JOURNAL OF UROLOGY (2017)
Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
Antti Haring et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2017)
Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Sean Harrison et al.
CANCER CAUSES & CONTROL (2016)
Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men
Rachel Dankner et al.
DIABETOLOGIA (2016)
The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels
Viranda H. Jayalath et al.
PROSTATE (2016)
Tumor features and survival after radical prostatectomy among antidiabetic drug users
R. M. Joentausta et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)
Marco Randazzo et al.
WORLD JOURNAL OF UROLOGY (2015)
Metformin Use and Prostate Cancer Risk
Mark A. Preston et al.
EUROPEAN UROLOGY (2014)
Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)
Christian Rothermundt et al.
EUROPEAN UROLOGY (2014)
Discrepancies between guidelines and clinical practice regarding prostate-specific antigen testing
Esther H. J. Hamoen et al.
FAMILY PRACTICE (2013)
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
Tuomas P. Kilpelainen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Association Between Metformin Use and Risk of Prostate Cancer and Its Grade
David Margel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer
Josephine Kang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
Brandon L. Pierce
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and Treatment study)
Emma L. Turner et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The Effect of Demographic and Clinical Factors on the Relationship Between BMI and PSA Levels
Jonathan L. Wright et al.
PROSTATE (2011)
The Effects of Type 2 Diabetes and Hypertension on Changes in Serum Prostate Specific Antigen Levels: Results From the Olmsted County Study
Lauren P. Wallner et al.
UROLOGY (2011)
Association of Diabetes and Body Mass Index with Levels of Prostate-Specific Antigen: Implications for Correction of Prostate-Specific Antigen Cutoff Values?
Heiko Mueller et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer
Lionel L. Banez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002
David M. Werny et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
The association of body mass index and prostate-specific antigen in a population-based study
J Baillargeon et al.
CANCER (2005)
Share Paper
